123 related articles for article (PubMed ID: 12666140)
1. Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplant.
Rosenblum MD; Bredeson CN; Chang CC; Rizzo JD
Am J Hematol; 2003 Apr; 72(4):274-7. PubMed ID: 12666140
[TBL] [Abstract][Full Text] [Related]
2. Localized extramedullary relapse after autologous hematopoietic stem cell transplantation in multiple myeloma.
Erkus M; Bolaman Z; Meteoglu I; Kadikoylu G
Saudi Med J; 2005 Jun; 26(6):989-91. PubMed ID: 15983690
[TBL] [Abstract][Full Text] [Related]
3. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma first observed as multiple cutaneous plasmacytomas.
Shah A; Klimo P; Worth A
Arch Dermatol; 1982 Nov; 118(11):922-4. PubMed ID: 6814367
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous metastatic plasmacytomas with tropism for a previously injured limb.
Pereira MA; Baudrier T; Costa A; Magalhães J; Azevedo F
Dermatol Online J; 2008 Sep; 14(9):16. PubMed ID: 19061598
[TBL] [Abstract][Full Text] [Related]
6. [Relapse of multiple myeloma in extramedullary sites].
Bairey O; Huminer D; Blickstein D; Sandbank Y; Shaklai M
Harefuah; 1993 May; 124(9):539-41, 600. PubMed ID: 8340001
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous localization of multiple myeloma on the tract of a central venous catheter].
Kerob D; Vantelon JM; Ribrag V; Bosq J; Desruennes E; Bourhis JH; Avril MF
Ann Dermatol Venereol; 2002 Mar; 129(3):311-4. PubMed ID: 11988688
[TBL] [Abstract][Full Text] [Related]
8. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
[TBL] [Abstract][Full Text] [Related]
10. [Gross spreading multiple extramedullary plasmacytomas to the skin in the terminal stage of multiple myeloma].
Kanno M; Nakamura S; Danno D; Uotani C; Kotani T; Yamanaka S; Terasaki Y; Matano S; Okumura H
Rinsho Ketsueki; 2001 Jul; 42(7):554-8. PubMed ID: 11524846
[TBL] [Abstract][Full Text] [Related]
11. Stomatococcus mucilaginosus meningitis in a patient with multiple myeloma following autologous stem cell transplantation.
Abraham J; Bilgrami S; Dorsky D; Edwards RL; Feingold J; Hill DR; Tutschka PJ
Bone Marrow Transplant; 1997 Mar; 19(6):639-41. PubMed ID: 9085747
[TBL] [Abstract][Full Text] [Related]
12. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
[TBL] [Abstract][Full Text] [Related]
13. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
Terpos E; Rezvani K; Basu S; Milne AE; Rose PE; Scott GL; Rahemtulla A; Samson D; Apperley JF
Eur J Haematol; 2005 Nov; 75(5):376-83. PubMed ID: 16191086
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
Am J Hematol; 2008 Aug; 83(8):614-7. PubMed ID: 18429054
[TBL] [Abstract][Full Text] [Related]
17. Outcome of unrelated transplants in patients with multiple myeloma.
Ballen KK; King R; Carston M; Kollman C; Nelson G; Lim S; Reece D; Giralt S; Vesole DH
Bone Marrow Transplant; 2005 Apr; 35(7):675-81. PubMed ID: 15723085
[TBL] [Abstract][Full Text] [Related]
18. Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.
Tapprich C; Fenk R; Schneider P; Bernhardt A; Haas R; Kobbe G
Bone Marrow Transplant; 2003 Sep; 32(6):629-31. PubMed ID: 12953137
[TBL] [Abstract][Full Text] [Related]
19. Stiff-person syndrome associated with multiple myeloma following autologous bone marrow transplantation.
Clow EC; Couban S; Grant IA
Muscle Nerve; 2008 Dec; 38(6):1649-52. PubMed ID: 18932204
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
Patriarca F; Prosdocimo S; Tomadini V; Vasciaveo A; Bruno B; Fanin R
Haematologica; 2005 Feb; 90(2):278-9. PubMed ID: 15710593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
